Provided by Tiger Fintech (Singapore) Pte. Ltd.

IGM Biosciences

1.13
-0.0300-2.59%
Post-market: 1.130.00000.00%16:09 EDT
Volume:149.06K
Turnover:168.51K
Market Cap:67.55M
PE:-0.35
High:1.16
Open:1.15
Low:1.10
Close:1.16
Loading ...
Mar 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 07, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 07, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Mar 07, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 10, 2025

Major Issues Report

Form 8-K - Current report
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Nov 08, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 03, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 05, 2024

Major Issues Report

Form 8-K - Current report
Jul 02, 2024

Correspondence

Form CORRESP - Correspondence
Jun 14, 2024

Major Issues Report

Form 8-K - Current report